Sign in

CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203857670
Phone
844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
  1. 3 Insider Initial Statement of Ownership
  2. SC 13D Stake Beneficial Ownership Report
  3. SC 13D Stake Beneficial Ownership Report
  4. 3 Insider Initial Statement of Ownership
  5. 4 Insider Changes in Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  14. DEFA14A Proxy Proxy Materials
  15. 10-Q Report Quarterly Report
  16. UPLOAD Other SEC-generated Letter
  17. DEFM14A Deal DEFM14A
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. PRER14A Other PRER14A
  20. 8-K Event Delisting notice

Page 17 of 36 · 703 filings